SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistel, LLP (www.JohnsonFistula.com) investigates whether Establishment Labs Holdings Inc. (“Establishment Labs” or the “company“) (NASDAQ:ESTA), any of its officers or others have violated securities laws by misrepresenting or failing to disclose in a timely manner material, adverse information to investors. The investigation focuses on investors’ losses and whether they were subject to the Federal securities laws can be reclaimed.

What if I bought Establishment Labs common stock? If you have purchased Establishment Labs common stock and suffered significant losses on your investment, join our investigation now:

Click or paste the following web address into your browser to submit your losses: https://www.johnsonfistel.com/investigations/establishment-labs-holdings-inc

Or contact Jim Baker at for more information [email protected] or (619) 814-4471

There are no costs or obligations for you.

What does Johnson examine fistula? On October 19, 2022, Hindenburg Research published a brief report on the operations of Establishment Labs. The report expresses his concerns about the company, particularly regarding the safety of its product and its conflict of interest. The article goes on to say that “Australian and French regulators have raised concerns about the company’s data, with Australian regulators describing the company’s key safety data as ‘uncontrolled observational studies.'” The article also states that “plastic surgeons from Italy and Argentina wrote a letter – the editor of the 2019 Aesthetic Surgery Journal, challenging the company’s touted “expert consensus” recommendation for Motiva implants. The physicians referred to the data as a ‘survey’, some of which was collected ‘electronically’. Questionnaires delivered via Survey Monkey.'”

According to this report, the share price fell by 17% when the market opened on October 19, 2022.

What if I have relevant…